These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 28112185)

  • 1. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
    He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
    Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
    Jiang Q; Wang S; Shi Y
    J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Defensive Action of LYRM03 on LPS-Induced Acute Lung Injury by NF-κB/TLR4/NLRP3 Signals.
    Wang B; Wang J; Lu D; Qi N; Liu Q
    J Invest Surg; 2021 Mar; 34(3):284-296. PubMed ID: 31274341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
    Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
    J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protostemonine effectively attenuates lipopolysaccharide-induced acute lung injury in mice.
    Wu YX; He HQ; Nie YJ; Ding YH; Sun L; Qian F
    Acta Pharmacol Sin; 2018 Jan; 39(1):85-96. PubMed ID: 29047459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
    Feng G; Jiang ZY; Sun B; Fu J; Li TZ
    Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
    Wang C; Li Q; Li T
    Exp Lung Res; 2020; 46(1-2):11-22. PubMed ID: 31931639
    [No Abstract]   [Full Text] [Related]  

  • 11. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
    Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
    Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
    Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin attenuates LPS-induced acute lung injury via inhibition of the TLR4/MyD88 signaling axis.
    Li X; Huang R; Liu K; Li M; Luo H; Cui L; Huang L; Luo L
    Aging (Albany NY); 2020 Dec; 13(2):2655-2667. PubMed ID: 33323555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sesamin Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibition of TLR4 Signaling Pathways.
    Qiang L; Yuan J; Shouyin J; Yulin L; Libing J; Jian-An W
    Inflammation; 2016 Feb; 39(1):467-472. PubMed ID: 26468152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect and mechanism study of L-cysteine derivative 5P39 on LPS-induced acute lung injury in mice.
    He Y; Zhao Y; Feng Y; Ren A; Zhang Y; Wang Y; Li H
    Eur J Pharmacol; 2020 Feb; 869():172893. PubMed ID: 31883915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Oligomeric Form of Surfactant Protein D in Murine Acute Lung Injury Induces M1 Subtype Macrophages Through Calreticulin/p38 MAPK Signaling Pathway.
    Li D; Pan L; Zhang X; Jiang Z
    Front Immunol; 2021; 12():687506. PubMed ID: 34484184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.
    Joh EH; Gu W; Kim DH
    Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
    Tang Y; Chen Y; Chu Z; Yan B; Xu L
    Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
    Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
    Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.